Improved Global Safety Monitoring of HIV Drugs Is Needed July 6,
2011 With at least five million people worldwide taking
antiretroviral therapy for HIV infection, the International
Forum for Collaborative HIV Research, in a PLoS Medicine Policy
Forum published on Tuesday, "recommends that improved and
sustained global drug safety monitoring, including monitoring
for substandard products, drug diversion, inappropriate use, and
toxicity, is critical," a press release from PLoS states. In a
recent meeting, key stakeholders "discussed the creation of a
sustainable global pharmacovigilance system for antiretroviral
drugs," according to the release (7/5). This article was
provided by Henry J. Kaiser Family Foundation. It is a part of
the publication Kaiser Daily Global Health Policy Report. Visit
the Kaiser Family Foundation's website to find out more about
their activities, publications and services. Add Your Comment:
(Please note: Your name and comment will be public, and may even
show up in Internet search resul